Nulibry ইউরোপীয় ইউনিয়ন - স্লোভেনীয় - EMA (European Medicines Agency)

nulibry

tmc pharma (eu) limited - fosdenopterin hydrobromide dihydrate - metal metabolism, inborn errors - drugi zdravljene bolezni prebavil in presnove izdelki, - nulibry is indicated for the treatment of patients with molybdenum cofactor deficiency (mocd) type a.